Manufacturers Life Insurance Company, The 9 Meters Biopharma, Inc. Transaction History

Manufacturers Life Insurance Company, The

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.26 - $0.64 $27,149 - $66,830	-104,423 Closed	0 $0
Q1 2022 Aug 11, 2023	BUY	$0.52 - $1.0 $54,299 - $104,423	104,423 New	104,423 $62,000
Q1 2022 May 20, 2022	SELL	$0.52 - $1.0 $13,672 - $26,293	-26,293 Reduced 20.11%	104,423 $63,000
Q4 2021 Feb 16, 2022	SELL	$0.85 - $1.33 $6,150 - $9,623	-7,236 Reduced 5.25%	130,716 $128,000
Q3 2021 Nov 12, 2021	SELL	$1.03 - $1.41 $3,479 - $4,762	-3,378 Reduced 2.39%	137,952 $179,000
Q2 2021 Aug 12, 2021	BUY	$1.04 - $1.5 $146,983 - $211,995	141,330 New	141,330 $155,000

67.9K

Ticker NMTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,955,400
Market Cap $259K
Description
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.